1. Home
  2. CURR vs MOLN Comparison

CURR vs MOLN Comparison

Compare CURR & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CURR
  • MOLN
  • Stock Information
  • Founded
  • CURR 2013
  • MOLN 2004
  • Country
  • CURR Singapore
  • MOLN Switzerland
  • Employees
  • CURR N/A
  • MOLN N/A
  • Industry
  • CURR Business Services
  • MOLN
  • Sector
  • CURR Consumer Discretionary
  • MOLN
  • Exchange
  • CURR Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • CURR 151.4M
  • MOLN 139.5M
  • IPO Year
  • CURR N/A
  • MOLN 2021
  • Fundamental
  • Price
  • CURR $1.85
  • MOLN $3.81
  • Analyst Decision
  • CURR Strong Buy
  • MOLN Hold
  • Analyst Count
  • CURR 1
  • MOLN 1
  • Target Price
  • CURR $3.50
  • MOLN $4.00
  • AVG Volume (30 Days)
  • CURR 215.1K
  • MOLN 2.5K
  • Earning Date
  • CURR 11-18-2025
  • MOLN 11-05-2025
  • Dividend Yield
  • CURR N/A
  • MOLN N/A
  • EPS Growth
  • CURR N/A
  • MOLN N/A
  • EPS
  • CURR N/A
  • MOLN N/A
  • Revenue
  • CURR $41,092,419.00
  • MOLN $856,302.00
  • Revenue This Year
  • CURR N/A
  • MOLN N/A
  • Revenue Next Year
  • CURR $14.56
  • MOLN $1,000.00
  • P/E Ratio
  • CURR N/A
  • MOLN N/A
  • Revenue Growth
  • CURR N/A
  • MOLN N/A
  • 52 Week Low
  • CURR $0.33
  • MOLN $3.36
  • 52 Week High
  • CURR $7.08
  • MOLN $7.60
  • Technical
  • Relative Strength Index (RSI)
  • CURR 60.14
  • MOLN 52.44
  • Support Level
  • CURR $1.67
  • MOLN $3.70
  • Resistance Level
  • CURR $1.97
  • MOLN $3.92
  • Average True Range (ATR)
  • CURR 0.09
  • MOLN 0.08
  • MACD
  • CURR 0.02
  • MOLN 0.01
  • Stochastic Oscillator
  • CURR 70.93
  • MOLN 52.50

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: